Home · Research Catalog · Thymulin

Specialty Research · Research Compound

Thymulin: Research Overview

What is thymulin? Thymulin is a nonapeptide thymic hormone that requires a bound zinc ion to adopt its biologically active conformation; the zinc-free form is designated the inactive precursor. It appears in preclinical research on thymic function and the neuroendocrine-immune axis, and is supplied strictly for laboratory research use.
VP Peptides verified packaging with independent COA and QR authentication
Verified VP Peptides packaging · COA with every batch · scan to verify
≥99% HPLC purity COA with every batch 3rd-party tested Research use only

Technical profile

CompoundThymulin (zinc-thymulin; historically serum thymic factor, FTS)
ClassNonapeptide (9 amino acids); zinc-dependent thymic hormone
Zinc dependenceRequires a coordinated Zn²⁺ ion for the biologically active conformation; the apo (zinc-free) peptide is the inactive precursor form
OriginOriginally characterised as a thymic epithelial factor detectable in serum; research material is produced synthetically
Molecular weight~857 g/mol (approximate, peptide component)
Form suppliedLyophilized powder, sealed vial
StorageLyophilized: 2–8 °C, protected from light.
VerificationHPLC purity ≥99%, sterility, endotoxins, heavy metals — documented on the batch COA

What does the research literature cover?

Thymulin is studied primarily as a probe for thymic endocrine function and for the interface between the nervous, endocrine, and immune systems. Published preclinical research covers:

Important context: these summaries describe what researchers have published in preclinical systems. They are not claims about what the research material supplied here does in humans, and VP Peptides makes no representation regarding immune function, thymic activity, safety, or efficacy in humans. Thymulin has no approved human use in any jurisdiction.

Why purity matters for thymulin research

Thymulin is unusual among research peptides in that its behaviour depends on a bound metal ion, which makes both peptide identity and the metal environment of the experiment relevant. Contaminating trace metals, chelating buffer components, or an incorrectly synthesised peptide backbone can all change what an assay reads out — and none of it is apparent without documentation of what is in the vial. Every VP Peptides thymulin batch ships with a Certificate of Analysis documenting ≥99% HPLC purity plus sterility, endotoxin and heavy-metal testing from independent third-party testing.

Request catalog access

Frequently asked questions

Is thymulin approved for human use?

No. Thymulin is not approved by the FDA or any other regulatory agency for human or veterinary use. It is supplied strictly as a research chemical for in-vitro and laboratory investigation, and it is not a drug, supplement, or food ingredient. The published literature on thymulin is preclinical.

Why is zinc relevant to thymulin?

Thymulin's active conformation depends on a coordinated zinc ion. The peptide isolated or synthesised without that ion is the inactive precursor form. This is why the literature frequently distinguishes zinc-thymulin from the apo peptide, and why the zinc content of buffers and media is a documented experimental variable in thymulin studies.

What does a thymulin Certificate of Analysis include?

Each batch COA documents HPLC purity (≥99% specification), sterility, endotoxin and heavy-metal screening results, along with batch number and test date.

How should thymulin be stored in the lab?

Lyophilized vials should be kept at 2–8 °C and protected from light.

A closer look at the T-cell and neuroimmune literature

Beyond the broad categories above, the preclinical record on thymulin has a fairly specific shape worth summarising for anyone designing an experiment around the peptide. Thymulin was originally isolated as a product of thymic epithelial cells, and much of the foundational work characterised it as a zinc-dependent factor examined in relation to the maturation of T lymphocytes. In cell-culture and rodent systems, investigators have used thymulin as a probe for markers associated with the differentiation of T-cell subsets, and the requirement for a coordinated zinc ion is a recurring analytical theme: the same peptide backbone behaves differently depending on whether the metal is present, which is why the literature carefully distinguishes zinc-thymulin from the apo precursor (Dardenne et al., 1994).

A second, well-documented strand concerns the thymus–neuroendocrine interface. Reviews of this area describe thymulin as a reference molecule for studying bidirectional signalling between thymic tissue and hormonal systems in animal models — a body of work sometimes grouped under neuroimmunomodulation (Reggiani et al., 2009). Earlier descriptions of the peptide as a zinc-dependent hormone laid out the framework that later studies built upon (Bach & Dardenne, 1989).

Two points bear repeating. First, all of this is preclinical: the cited work describes observations in cells and animals, not effects of the research material in humans. Second, because a thymulin readout depends on its metal environment, both the identity and purity of the peptide and the zinc content of the assay are experimental variables that need documentation — which is precisely what a batch Certificate of Analysis records.

Selected research references

Related research compounds

Research use only. All products described on this page are furnished for laboratory research purposes only and are not for human or veterinary use, not for use in food or cosmetics, and not for any diagnostic or therapeutic application. Nothing on this page is medical advice or a claim of safety or efficacy in humans. Research summaries reference publicly available preclinical literature; specific citations are listed in the references above.